Direxion Daily S&P Biotech Bear 3X ETF
FThis fund multiplies its index's move each day and resets that multiple daily. Because daily returns compound, its long-run return can differ from the headline multiple.
The ETF.net LABD Grade
F
Score 19 out of 100
- 14 of 14
Score 19 of 100 falls in the F band. A is 70 or higher, B 55 to under 70, C 40 to under 55, D 25 to under 40, F under 25.
Cost
The fund’s net expense ratio, ranked against its category.F5 out of 100Rank 13 of 14Mission
Whether the fund did what it promised, tested against its stated mandate.Risk
How the fund held up when markets fell: downside volatility, drawdowns and tail loss.F15 out of 100Rank 13 of 14Tradability
How easy the fund is to trade: daily volume, and how far its price strays from net asset value.C46 out of 100Rank 8 of 14Holdings
How concentrated the fund is, and how complete and current its disclosed holdings are.Durability
Whether the fund is likely to stay open, judged by its age, its assets and its issuer’s assets.C46 out of 100Rank 8 of 14
Our read on LABD
In short
FBiotech headlines cut both ways, and LABD takes the short side at triple speed: it aims for 300% of the inverse daily move in the S&P Biotechnology Select Industry Index, reset every close.
Stated mandate
The fund seeks daily investment results equal to 300% of the inverse performance of the S&P Biotechnology Select Industry Index, before fees and expenses.
Why people hold it
Worth knowing
LABD Holdings
- Other
- 6
- 137%
- Spsibi Swap Asset Leg (Spsibimls)
LABD Performance
Shows how $10,000 changes over the selected period, with cash distributions reinvested at the closing price on each ex-dividend date.
LABD$2,572
Returns run to the Oct 30, 2026 close, with cash distributions reinvested. Each period starts on the same date that many months or years earlier. Periods over one year show the average yearly return.
| Period | LABD |
|---|---|
| Year to date | −66.1% |
| 1 month | −0.7% |
| 3 months | −24.5% |
| 1 year | −74.3% |
| 3 years | −69.3% |
| 5 years | −48.1% |
| 10 years | −58.5% |
Calendar-year total return with cash distributions hypothetically reinvested at the ex-dividend date’s closing price. The current year shows year to date.
| Year | Return bar | LABD |
|---|---|---|
| 2026 YTD | −66.1% | |
| 2025 | −70.1% | |
| 2024 | −21.4% | |
| 2023 | −41.8% | |
| 2022 | −32.7% |
LABD in the news
LABD Dividends
- 6.59%
- $0.46
- $0.07 per share
- Quarterly
LABD Risk
This fund targets a multiple of the daily move of its index and resets daily. Hold it longer than one reset and compounding makes the return diverge from that target. In choppy markets it can lose value even when the index ends flat.
- 68.2%
How it’s calculated: standard deviation
The sample standard deviation of monthly total returns, multiplied by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Total returns include reinvested distributions.
- −1.36
How it’s calculated: Sharpe ratio
Subtract each month’s Treasury-bill return from the fund’s monthly total return.
Divide the average of those excess returns by their sample standard deviation, then multiply by the square root of 12.
Uses up to 36 complete months, with at least 12 required. Each month uses the Treasury yield quoted at the end of the previous month.
- −99.2%
How it’s calculated: maximum drawdown
The largest percentage decline from an earlier peak, using total returns with reinvested distributions.
Uses up to five years through the last close, with at least 12 months required.
- −3.12
How it’s calculated: beta
The beta figure is supplied by FMP. The comparison index depends on the fund’s broad asset class.
FMP measures it over up to five years of monthly returns.
LABD Cost
Overpaying vs SQQQ, cheapest in 3x Leveraged Inverse
$2,111
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
LABD 1.07%
$19,815
SQQQ 0.94% Cheapest
$17,704
Cost over time
Year by year
| Year | LABD | SQQQ | Overpaying |
|---|---|---|---|
| 10 | $1,881 | $1,661 | $220 |
| 20 | $7,046 | $6,260 | $786 |
| 30 | $19,815 | $17,704 | $2,111 |
You pay 1.07%Waived by Direxion 0.01%
Full fee 1.08% waiver 0.01% you pay 1.07%
Other funds in 3x Leveraged Inverse
- CSMDDProShares UltraPro Short MidCap400Expense ratio 0.95%1 year return −32.1%
- DDRVDirexion Daily Real Estate Bear 3X ETFExpense ratio 1.06%1 year return −21.1%
- DEDZDirexion Daily MSCI Emerging Markets Bear 3X ETFExpense ratio 1.05%1 year return −45.3%
- FHIBSDirexion Daily S&P 500 High Beta Bear 3X ETFExpense ratio 1.06%1 year return −59.4%
- FWEBSDirexion Daily Dow Jones Internet Bear 3X ETFExpense ratio 1.07%1 year return +5.6%